GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AC Immune ACIU · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.44

+9.42%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

AC Immune annual report

Filed with the US Securities and Exchange Commission

20-F

The latest annual report covers the year to 31 Dec 2025, filed on 13 Mar 2026.

Read the 20-F on SEC.gov ↗

Five-year highlights

In CHF.

FY2025FY2024FY2023FY2022FY2021
RevenueCHF 3.6mCHF 27.3mCHF 14.8mCHF 3.9mCHF 944,000
Operating income−CHF 68.9m−CHF 52.4m−CHF 53.6m−CHF 70.8m−CHF 79.0m
Net income−CHF 70.4m−CHF 50.9m−CHF 54.2m−CHF 70.8m−CHF 73.0m
Free cash flow−CHF 67.0mCHF 65.3m−CHF 61.2m−CHF 74.8m−CHF 68.3m
Total assetsCHF 154.4mCHF 230.9mCHF 182.8mCHF 185.9mCHF 261.4m
Shareholders' equityCHF 44.9mCHF 112.3mCHF 160.6mCHF 169.0mCHF 232.0m

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.